Login / Signup

The effects of synbiotics on the liver steatosis, inflammation, and gut microbiome of metabolic dysfunction-associated liver disease patients-randomized trial.

Miloš MitrovićAna DobrosavljevićOlga OdanovićTamara Knežević-IvanovskiĐorđe KraljSanja ErcegAna PerućicaPetar SvorcanVerica Stanković-Popović
Published in: Romanian journal of internal medicine = Revue roumaine de medecine interne (2024)
Synbiotics could be an effective and safe option that could have place in MASLD treatment.
Keyphrases
  • end stage renal disease
  • oxidative stress
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • insulin resistance
  • patient reported outcomes
  • high fat diet induced